Answers are grounded in this paper and cite their sources.
Quadrivalent HPV vaccine seems generally safe and well tolerated in this series of adolescents and young women with SLE, with no increase in mean SLEDAI scores. Progression to renal failure in two patients was most likely secondary to pre-existing severe renal chronicity and not secondary to HPV vaccination. Immunogenicity to the quadrivalent HPV vaccine was excellent, with the seropositivity rate >94% in all four HPV types.
No takes yet. Share an insight, caveat, or question.
Soybilgic et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: